MIDAS Network Publications

Found 67 results
Filters: Author is Lee, Bruce Y  [Clear All Filters]
2013
Haidari LA, Connor DL, Wateska AR, Brown ST, Mueller LE, Norman BA, Schmitz MM, Paul P, Rajgopal J, Welling JS et al..  2013.  Augmenting transport versus increasing cold storage to improve vaccine supply chains.. PLoS One. 8(5):e64303.
van Panhuis WG, Grefenstette J, Jung SYon, Chok NShong, Cross A, Eng H, Lee BY, Zadorozhny V, Brown S, Cummings D et al..  2013.  Contagious diseases in the United States from 1888 to the present.. N Engl J Med. 369(22):2152-8.
Bartsch SM, Umscheid CA, Fishman N, Lee BY.  2013.  Is fidaxomicin worth the cost? An economic analysis. Clin Infect Dis. 57(4):555-61.
Everett KH, Potter MA, Wheaton WD, Gleason SM, Brown ST, Lee BY.  2013.  Geospatial analytics to evaluate point-of-dispensing sites for mass immunizations in Allegheny County, Pennsylvania.. J Public Health Manag Pract. 19 Suppl 2:S31-6.
Lee BY, Bacon KM, Bottazzi MElena, Hotez PJ.  2013.  Global economic burden of Chagas disease: a computational simulation model.. Lancet Infect Dis. 13(4):342-8.
Lee BY, S Yilmaz L, Wong KF, Bartsch SM, Eubank S, Song Y, Avery TR, Christie R, Brown ST, Epstein JM et al..  2013.  Modeling the regional spread and control of vancomycin-resistant enterococci.. Am J Infect Control. 41(8):668-73.
Haidari LA, Connor DL, Wateska AR, Brown ST, Mueller LE, Norman BA, Schmitz MM, Paul P, Rajgopal J, Welling JS et al..  2013.  Only adding stationary storage to vaccine supply chains may create and worsen transport bottlenecks.. J Public Health Manag Pract. 19 Suppl 2:S65-7.
Bacon KM, Hotez PJ, Kruchten SD, Kamhawi S, Bottazzi MElena, Valenzuela JG, Lee BY.  2013.  The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas.. Vaccine. 31(3):480-6.
Lee BY, Singh A, Bartsch SM, Wong KF, Kim DS, Avery TR, Brown ST, Murphy CR, S Yilmaz L, Huang SS.  2013.  The potential regional impact of contact precaution use in nursing homes to control methicillin-resistant Staphylococcus aureus.. Infect Control Hosp Epidemiol. 34(2):151-60.
Lee BY, Wong KF, Bartsch SM, S Yilmaz L, Avery TR, Brown ST, Song Y, Singh A, Kim DS, Huang SS.  2013.  The Regional Healthcare Ecosystem Analyst (RHEA): a simulation modeling tool to assist infectious disease control in a health system.. J Am Med Inform Assoc. 20(e1):e139-46.
Assi T-M, Brown ST, Kone S, Norman BA, Djibo A, Connor DL, Wateska AR, Rajgopal J, Slayton RB, Lee BY.  2013.  Removing the regional level from the Niger vaccine supply chain.. Vaccine. 31(26):2828-34.
2012
Lee BY, Bartsch SM, Willig AM.  2012.  The economic value of a quadrivalent versus trivalent influenza vaccine.. Vaccine. 30(52):7443-6.
Lee BY, Bacon KM, Shah M, Kitchen SBeth, Connor DL, Slayton RB.  2012.  The economic value of a visceral leishmaniasis vaccine in Bihar state, India.. Am J Trop Med Hyg. 86(3):417-25.
Assi T-M, Rookkapan K, Rajgopal J, Sornsrivichai V, Brown ST, Welling JS, Norman BA, Connor DL, Chen S-I, Slayton RB et al..  2012.  How influenza vaccination policy may affect vaccine logistics.. Vaccine. 30(30):4517-23.
Lee BY, Cakouros BE, Assi T-M, Connor DL, Welling J, Kone S, Djibo A, Wateska AR, Pierre L, Brown ST.  2012.  The impact of making vaccines thermostable in Niger's vaccine supply chain.. Vaccine. 30(38):5637-43.
Lee BY, Bacon KM, Wateska AR, Bottazzi MElena, Dumonteil E, Hotez PJ.  2012.  Modeling the economic value of a Chagas' disease therapeutic vaccine.. Hum Vaccin Immunother. 8(9):1293-301.
Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY.  2012.  The potential economic value of a human norovirus vaccine for the United States.. Vaccine. 30(49):7097-104.
Song Y, H Y Tai J, Bartsch SM, Zimmerman RK, Muder RR, Lee BY.  2012.  The potential economic value of a Staphylococcus aureus vaccine among hemodialysis patients.. Vaccine. 30(24):3675-82.
Lee BY, H Y Tai J, McGlone SM, Bailey RR, Wateska AR, Zimmer SM, Zimmerman RK, Wagner MM.  2012.  The potential economic value of a 'universal' (multi-year) influenza vaccine.. Influenza Other Respir Viruses. 6(3):167-75.
Potter MA, Brown ST, Lee BY, Grefenstette J, Keane CR, Lin CJ, Quinn SC, Stebbins S, Sweeney PM, Burke DS.  2012.  Preparedness for pandemics: does variation among states affect the nation as a whole? J Public Health Manag Pract. 18(3):233-40.
Lee BY, Shah M.  2012.  Prevention of influenza in healthy children.. Expert Rev Anti Infect Ther. 10(10):1139-52.
Potter MA, Brown ST, Cooley PC, Sweeney PM, Hershey TB, Gleason SM, Lee BY, Keane CR, Grefenstette J, Burke DS.  2012.  School closure as an influenza mitigation strategy: how variations in legal authority and plan criteria can alter the impact.. BMC Public Health. 12:977.
Lee BY, Bartsch SM, Wong KF, S Yilmaz L, Avery TR, Singh A, Song Y, Kim DS, Brown ST, Potter MA et al..  2012.  Simulation shows hospitals that cooperate on infection control obtain better results than hospitals acting alone.. Health Aff (Millwood). 31(10):2295-303.
Mitchell MD, Hong JA, Lee BY, Umscheid CA, Bartsch SM, Don CW.  2012.  Systematic review and cost-benefit analysis of radial artery access for coronary angiography and intervention.. Circ Cardiovasc Qual Outcomes. 5(4):454-62.

Pages